Lack of correlation between results of ABO-incompatible living kidney transplantation and anti-ABO blood type antibody titers under our current immunosuppression

Transplantation

Volumn 80, Issue 7, 2005, Pages 985-988

  Shimmura, Hiroaki ^a,b   Tanabe, Kazunari ^a   Ishida, Hideki ^a   Tokumoto, Tadahiko ^a   Ishikawa, Nobuo ^a   Miyamoto, Naoshi ^a   Shirakawa, Hiroki ^a   Setoguchi, Kiyoshi ^a   Nakajima, Ichiro ^a   Fuchinoue, Shouhei ^a   Teraoka, Satoshi ^a   Toma, Hiroshi ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^b NONE   (Japan)

Author keywords

Blood type incompatible; Humoral rejection; Kidney transplantation; Mycophenolate mofetil; Tacrolimus

Indexed keywords

15 DEOXYSPERGUALIN; AZATHIOPRINE; BLOOD GROUP ABO ANTIBODY; BLOOD GROUP ANTIBODY; CYCLOSPORIN; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; LYMPHOCYTE ANTIBODY; METHYLPREDNISOLONE; MIZORIBINE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OKT 3; TACROLIMUS; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ANTIBODY TITER; ARTICLE; BLOOD GROUP ABO INCOMPATIBILITY; BLOOD GROUP ABO SYSTEM; CHILD; CORRELATION ANALYSIS; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY TRANSPLANTATION; LIVING DONOR; MAJOR CLINICAL STUDY; MALE; PREOPERATIVE PERIOD; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE;

ABO BLOOD-GROUP SYSTEM; ADOLESCENT; ADULT; AGED; ANTIBODIES; BLOOD GROUP INCOMPATIBILITY; CHILD; CHILD, PRESCHOOL; FEMALE; GRAFT SURVIVAL; HISTOCOMPATIBILITY; HUMANS; IMMUNOGLOBULIN G; IMMUNOSUPPRESSION; KIDNEY TRANSPLANTATION; LIVING DONORS; MALE; MIDDLE AGED;

EID: 27644529718     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.tp.0000173647.43616.78     Document Type: Article

References (13)

1. Tanabe K, Takahashi K, Sonda K, et al. Long-term results of ABO-incompatible living kidney transplantation: a single-center experience. Transplantation 1998; 65: 224-228.
2. Gloor JM, Lager DJ, Moore SB, et al. ABO-incompatible kidney transplantation using both A2 and non-A2 living donors. Transplantation 2003; 75: 971-977.
3. Tyden G, Kumlien G, Fehrman I. Successful ABO-incompatible kidney transplantations without splenectomy using antigen-specific immunoadsorption and rituximab. Transplantation 2003; 76: 730-731.
4. Montgomery RA, Cooper M, Kraus E, et al. Renal transplantation at the Johns Hopkins Comprehensive Transplant Center. Clin Transpl 2003; 199-213.
5. Kayler LK, Colombe B, Farber JL, et al. Successful living donor renal transplantation despite ABO incompatible and a positive crossmatch. Clin Transplant 2004; 18: 737-742.
6. Shimmura H, Tanabe K, Ishikawa N, et al. Role of anti-A/B antibody titers in results of ABO-incompatible kidney transplantation. Transplantation 2000; 70: 1331-1335.
7. Tanabe K, Tokumoto T, Ishida H, et al. Excellent outcome of ABO-incompatible living kidney transplantation under pretransplantation immunosuppression with tacrolimus, mycophenolate mofetil, and steroid. Transplant Proc 2004; 36: 2175-2177.
8. Eugui EM, Almquist SJ, Muller CD, Allison AC. Lymphocyte-selective cytostatic and immunosuppressive effects of mycophenolic acid in vitro: role of deoxyguanosine nucleotide depletion. Scand J Immunol 1991; 33: 161-173.
9. Smith KG, Isbel NM, Carton MG, et al. Suppression of the humoral immune response by mycophenolate mofetil. Nephrol Dial Transplant 1998; 13: 160-164.
10. Ishida H, Tanabe K, Furusawa M, et al. Mycophenolate mofetil suppresses the production of anti-blood type antibodies after renal transplantation across the abo blood barrier: ELISA to detect humoral activity. Transplantation 2002; 74: 1187-1189.
11. Spencer CM, Goa KL, Gillis JC. Tacrolimus as update of its pharmacology and clinical efficacy in the management organ transplantation. Drugs 1997; 54: 925-975.
12. Thomson AW, Bonham CA, Zeevi A. Mode of action of tacrolimus (FK506): molecular and cellular mechanism. Ther Drug Monit 1995; 17: 584-591.
13. Ogawa H, Mohiuddin MM, Yin DP, et al. Mouse-heart grafts expressing an incompatible carbohydrate antigen. II. Transition from accommodation to tolerance. Transplantation 2004; 77: 366-373.